InVivo Therapeutics Corp Est. EPS Q/Q
What is the Est. EPS Q/Q of InVivo Therapeutics Corp?
The Est. EPS Q/Q of InVivo Therapeutics Holdings Corp is -35.71%
What is the definition of Est. EPS Q/Q?
Prospective quarterly EPS growth rate, year over year, is the estimated increase of the company’s EPS for the current quarter compared to performance from a past corresponding quarter.
= current quarter yoy (year over year)
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q/Q of companies in the Health Care sector on NASDAQ compared to InVivo Therapeutics Corp
What does InVivo Therapeutics Corp do?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Companies with est. eps q/q similar to InVivo Therapeutics Corp
- Chiasma Inc has Est. EPS Q/Q of -36.00%
- Tide Water Oil Co. (India) has Est. EPS Q/Q of -35.86%
- Fresenius Medical Care AG has Est. EPS Q/Q of -35.85%
- Exelon has Est. EPS Q/Q of -35.78%
- Exelon has Est. EPS Q/Q of -35.78%
- Mallinckrodt Plc has Est. EPS Q/Q of -35.75%
- InVivo Therapeutics Corp has Est. EPS Q/Q of -35.71%
- Calithera Biosciences Inc has Est. EPS Q/Q of -35.67%
- Allstate Corp has Est. EPS Q/Q of -35.64%
- DarioHealth Corp has Est. EPS Q/Q of -35.59%
- Perdoceo Education has Est. EPS Q/Q of -35.56%
- Aeglea BioTherapeutics Inc has Est. EPS Q/Q of -35.48%
- BioNTech SE has Est. EPS Q/Q of -35.42%